RT @JAMA_current: In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day…
RT @JAMA_current: In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day…
RT @JAMA_current: In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day…
RT @JAMA_current: In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day…
RT @JAMA_current: In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day…
Why randomized trials are necessary. Adjust for known, and unknown confounders, as well as bias & anecdotal "evidence."
RT @JAMA_current: In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day…
RT @JAMA_current: In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day…
In this large RCT, #hydroxychloroquine did not improve the clinical status of patients hospitalized with #COVID19 at day 14, compared with placebo https://t.co/9EsNWdJ8Fo @AditGinde @f2harrell @NickJohnsonMD @toddrice_ICU @DrSamuelBrown
@wjamesawill Studies found that it has no effect on Covid-19, good or bad (three links below). All three studies confirm that there was no difference between the medicated and the placebo groups. https://t.co/JH0FJqLWVG https://t.co/OrByDRtvau https://t
@fui5691 @James_Euro @morethanmySLE Let me assist you get past the very abbreviated presser: https://t.co/UJzBV1InYc
@agathopoios @SDECoxHealth This is why: https://t.co/h5ASQ1bvgP
@Mrtitannwheels @Nikki10042 @dillonhillier @randyhillier @IndConCan @shurmanator @am640 @fordnation @adamskely Yes, and one of those studies is the JAMA one I posted. Here it is again. https://t.co/BIXo0wgd2e
Dünyada, yönetimi okuma yazma bilen insanlardan oluşup da bu ilacı hala kullandıran tek bir ülke kalmadı. Herhalde son paralarımızla bolca stok almış bulundular, çöpe gitsin istemiyorlar. https://t.co/WdhWCXbXAo https://t.co/IzyIn4fQtK
@schrod_erwin @RationnelI @Scintigraphiste Mais tu vois je cherchais celle-là et je l'ai trouvée... donc c'est pas si mal https://t.co/fBtICPpBl6
@charliekirk11 Remember when lots of studies like these happened? https://t.co/BIqSzbi8Rn
@FatEmperor @burtymcbuttnut Ramdomised cylinical trail administering the correct dosage demonstrated that it does NOT work as a therapeutic. Read for yourself https://t.co/3IqOcwJqIb
RT @mathusale: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/TzsyxyYAKS @J…
RT @CyrilPedia: Once more unto the breach, dear friends 'Among adults hospitalized with respiratory illness from COVID-19, treatment with…
RT @CyrilPedia: Once more unto the breach, dear friends 'Among adults hospitalized with respiratory illness from COVID-19, treatment with…
RT @zenith_lp: RCT มาจ้าาาา น้องๆคนไหนหาทำ journal club จัดไป แล้วมาเล่าให้พี่ฟังหน่อยน้า 😂😂 Effect of Hydroxychloroquine on Clinical Sta…
Once more unto the breach, dear friends 'Among adults hospitalized with respiratory illness from COVID-19, treatment with hydroxychloroquine, compared with placebo, did not significantly improve clinical status at day 14.' https://t.co/yyJnXd47lo
RCT มาจ้าาาา น้องๆคนไหนหาทำ journal club จัดไป แล้วมาเล่าให้พี่ฟังหน่อยน้า 😂😂 Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network ht
RT @mathusale: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/TzsyxyYAKS @J…
RT @mathusale: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/TzsyxyYAKS @J…
RT @mathusale: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/TzsyxyYAKS @J…
@dcexaminer I can’t find any link to the study yet this latest one shows no difference. https://t.co/tII7KRqyNU. The better treatment without symptoms is dexamethasone.
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/TzsyxyYAKS @JAMA_current part of @JAMANetworkより
@xavierdreyman @pegobry No, this debacle. Note the RCT vs Retrospective distinction. https://t.co/FZ3OFEU8S3
@TheXiaojie Here are a few, including the two latest ones. https://t.co/Bxcc6esHL8 https://t.co/y9suIXigAV https://t.co/HR00XglX0S https://t.co/gL5b7w8Ozb
RT @f2harrell: Our #HydroxyChloroquine #Covid19 randomized trial led by colleague Wes Self + a great team was published in @JAMA_current -…
RT @f2harrell: Our #HydroxyChloroquine #Covid19 randomized trial led by colleague Wes Self + a great team was published in @JAMA_current -…
RT @pierrecallamand: Et toujours pas de preuve d’efficacité : Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Pa…
RT @pierrecallamand: Et toujours pas de preuve d’efficacité : Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Pa…
Et toujours pas de preuve d’efficacité : Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network https://t.co/wMqUJhc5YT
Science in action. So much for trump's BS... "These findings do not support the use of hydroxychloroquine for treatment of COVID-19 among hospitalized adults." https://t.co/PBii39WUMF
RT @elif_ergin: raporun tamamı: https://t.co/PqWLun7KO4
raporun tamamı: https://t.co/PqWLun7KO4
HCQ治療群のCOVID-19入院患者は、通常治療群に比べて28日以内の生存退院率が低い(59.6 vs 62.9%, 95%CI 0.83-0.98) 非挿管患者では、HCQ群では挿管/死亡頻度が高い(30.7 vs 26.9%, 95%CI 1.03-1.27) Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 https://t.co/k7MUPJrPsk https://t.co/Qv80mVMtTx
RT @MichelleNgGong: This is extremely disheartening. We need to focus on what works and not what is easier to swallow to avoid responsibil…
RT @MichelleNgGong: This is extremely disheartening. We need to focus on what works and not what is easier to swallow to avoid responsibil…
This is extremely disheartening. We need to focus on what works and not what is easier to swallow to avoid responsibility for hard decisions and work. Recent ORCHID trial again showed no benefit. And I quote from editorial, https://t.co/kW06gxigGT
RT @joex92_: @DrSamuelBrown In ORCHID trial you are referring to, patients least severe at baseline (hospitalized, without need of O2) fare…
RT @joex92_: @DrSamuelBrown In ORCHID trial you are referring to, patients least severe at baseline (hospitalized, without need of O2) fare…
@DrSamuelBrown In ORCHID trial you are referring to, patients least severe at baseline (hospitalized, without need of O2) fared way better in HCQ group. The effect was almost signifcant in this subgrup, check before last page in Supplement 3. https://t.co/
RT @GermHunterMD: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 HCQ still doesn’t wor…
@DalJeanis @TheRealHoarse Here is a current study (11/9) finding not benefit. https://t.co/uNDonkBaCs
@atrupar This has been long put to bed. The results of a large randomized trial comparing hydroxychloroquine to placebo were published in JAMA last week and showed no significant difference in outcomes for inpatients at 14 days. https://t.co/ZKJMzpWuhy
@thiago_o_s @mengobruno @luizanbc @oatila Opa, então segura esse ensaio clínico randomizado: https://t.co/3F2s3YvhhB
RT @EstebanOrtizMD: Hoy salió un trabajo que sepulta definitivamente a la #Hidroxicloroquina como estrategia para tratar #COVID19 en etapas…
RT @JAMA_current: New study findings do not support the use of #hydroxychloroquine for treatment of #COVID19 among hospitalized adults http…
RT @holistic_Hlth: #DHPSP #Hydroxychloroquine #COVID-19 Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients…
More evidence proving hydroxychloroquine has no role in the treatment of COVID-19. #COVID19 #hydroxycholoroquine https://t.co/AC38sGTXIL
L’ultimo (di tanti) studio pubblicato su JAMA (prestigiosa rivista medica) settimana scorsa conferma che l’idrossiclorochina non funziona...di nuovo. https://t.co/wZwR7y1V9U
Effect of #Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With #COVID19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | https://t.co/Zud1tiGNzk via @JAMA_current
@ReasonCritical @ThierryMoine2 @wef @Ipsos https://t.co/0VsiOs7x9G wow would you look at that. It's almost like when you CONTROL for placebo, Hydroxy actually doesnt do better. amazing isnt it. When you actually do a blind study, you get a result... imagi
The goal posts haven’t moved. This study doesn’t reach them. Symptoms for up to 10 days, dose of HCQ low, no Zn. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial https://t.co/r
As if we needed another study to show that HCQ has no place in COVID-19 https://t.co/5Bue4tmRXm
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/986HRMNlBZ via @JAMA_current part of @JAMANetwork
En adultos hospitalizados con enfermedad respiratoria por COVID, el tratamiento con hidroxicloroquina, comparado con placebo, no mejoraría el estado clínico para el día 14 https://t.co/SXs0XYYtw7 a través de @JAMA_current part of @JAMANetwork
RT @otavio_ranzani: Este trial parou na quarta análise interina por futilidade após 479 pacientes analisados. at @JAMA_current https://t…
RT @marybeth_bess: Randomized control trial in hospitalized patients with respiratory illness from COVID-19 finds no significant improveme…
Randomized control trial in hospitalized patients with respiratory illness from COVID-19 finds no significant improvement at Day 14 using Hydroxychloroquine: https://t.co/rkaYfCEOkx
Fauci/FDA won’t let info out. Ggl/FB/Twit censor info. THIS article is asinine, HCQ initiated after admit NOT effective. Why do you think VIP’s get melatonin, Pepcid & dex before sev symptoms-they’re anti-inflam-best outcomes if started prior to infla
@PoliticaLee1 @JodiDoering Why are we still talking about #HydroxyChloroquine? It Does Not Work https://t.co/L124ZYeha3? https://t.co/lp6jre2ZwX? .@andreacitymom .@benshapiro .@JackPosobiec .@dbongino .@chuckwoolery .@charliekirk11 .@LynnFynn3 .@MGillbert1
RT @NHLBI_Translate: .#JAMA publishes @NIH_NHLBI-funded #RCT: Effect of #hydroxychloroquine (HC) on clinical status at 14 days in hospitali…
HCQ RCT: https://t.co/Um8on62JEA
RT @NHLBI_Translate: .#JAMA publishes @NIH_NHLBI-funded #RCT: Effect of #hydroxychloroquine (HC) on clinical status at 14 days in hospitali…
RT @NHLBI_Translate: .#JAMA publishes @NIH_NHLBI-funded #RCT: Effect of #hydroxychloroquine (HC) on clinical status at 14 days in hospitali…
@NHLBI_Translate @nih_nhlbi @JAMA_current @TheLancet @bmj_latest @AnnalsofIM @AmerMedicalAssn @ahahospitals @American_Heart @harvardmed @HopkinsMedicine @UCSF um your study didn't show administering of Zinc? Without zinc you are pretending to remedy. its l
.#JAMA publishes @NIH_NHLBI-funded #RCT: Effect of #hydroxychloroquine (HC) on clinical status at 14 days in hospitalized patients with #COVID19. Compared with placebo, HC did not significantly improve clinical status at day 14. Not better than #placebo. h
Well, now we know. Multi center, randomized, placebo-controlled, blinded, study demonstrates no benefit vs placebo for covid positive patients that have been hospitalized. https://t.co/Lkicq7GD3N
The effectiveness of hydroxychloroquine for treatment of COVID-19 among hospitalized adults was not support. Read: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/NNLm8CHIMV via @JAMA_current p
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/VZjTorittR via @JAMA_current part of @JAMANetwork
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/FQrUGJcuE4 via @JAMA_current part of @JAMANetwork
Más evidencia por si queda algún despistado!
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/ON77CrenTu via @JAMA_current part of @JAMANetwork
Hydroxychloroquine of no benefit in hospitalized patients with COVID-19 https://t.co/OVhDNLkoq2 Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbAgzNS https://t.co/hpgZG8FDnA
Another study showing hydroxychloroquine doesn’t work. More and more evidence on this.
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/efrL4gKJrB @JAMA_current part of @JAMANetwork aracılığıyla 14 gün yatışı olan ve çift kör izlenen COVID-19 hastalarında kinin ve pelesebo kullan
RT @JAMA_current: New study findings do not support the use of #hydroxychloroquine for treatment of #COVID19 among hospitalized adults http…
RT @MathieuMolimard: Oui @ansm fait bien de ne pas donner de RTU #HydroxyChloroquine #Covid_19 Encore un essai négatif https://t.co/gVJlD…
Spoiler Alert: HCQ still doesn’t work for COVID
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 A Randomized Clinical Trial https://t.co/LfwP6U8QG8
RT @dukeemergency: Congrats to @J_Eppensteiner and all involved on their recent @JAMA_current pub: https://t.co/EhwDW5hdXf https://t.co/sf5…
RT @sreeja_natesan: Yes congrats @J_Eppensteiner !!
Again, #Hydroxychloroquine does not work against #Covid: Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 https://t.co/WVRVHxsJTF via @JAMA_current part of @JAMANetwork